Hepatitis C Virus Vaccine: Challenges and Prospects

The hepatitis C virus (HCV) causes both acute and chronic infection and continues to be a global problem despite advances in antiviral therapeutics. Current treatments fail to prevent reinfection and remain expensive, limiting their use to developed countries, and the asymptomatic nature of acute in...

Descripción completa

Detalles Bibliográficos
Autores principales: Duncan, Joshua D., Urbanowicz, Richard A., Tarr, Alexander W., Ball, Jonathan K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157504/
https://www.ncbi.nlm.nih.gov/pubmed/32079254
http://dx.doi.org/10.3390/vaccines8010090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157504/
https://www.ncbi.nlm.nih.gov/pubmed/32079254
http://dx.doi.org/10.3390/vaccines8010090

Ejemplares similares